Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:awards |
Best Technology Provider
Best Innovation in Clinical Trials |
| gptkbp:ceo |
gptkb:Dr._Iain_Mc_Gowan
|
| gptkbp:collaborates_with |
academic institutions
|
| gptkbp:develops |
digital cognitive tests
|
| gptkbp:employees |
over 50
|
| gptkbp:focuses_on |
neuropsychological tests
|
| gptkbp:founded |
gptkb:2004
|
| gptkbp:founder |
gptkb:Dr._Simon_W._Mc_Gowan
|
| gptkbp:has_client |
universities
hospitals biotechnology companies pharmaceutical companies research organizations |
| gptkbp:has_part |
gptkb:CANTAB_Connect
gptkb:CANTAB_Mobile gptkb:CANTAB_Research gptkb:CANTAB_for_Aging_Research gptkb:CANTAB_for_Anxiety_Disorders gptkb:CANTAB_for_Autism gptkb:CANTAB_for_Depression gptkb:CANTAB_for_Education gptkb:CANTAB_for_Healthcare gptkb:CANTAB_for_Mental_Health CANTAB for ADHD CANTAB for Alzheimer's Disease CANTAB for Bipolar Disorder CANTAB for Clinical Trials CANTAB for Cognitive Enhancement CANTAB for Cognitive Rehabilitation CANTAB for Cognitive Training CANTAB for Dementia CANTAB for Epilepsy CANTAB for Industry CANTAB for Multiple Sclerosis CANTAB for Neurodegenerative Diseases CANTAB for Neuropsychology CANTAB for Parkinson's Disease CANTAB for Performance Monitoring CANTAB for Research CANTAB for Schizophrenia CANTAB for Stroke CANTAB for Substance Use Disorders CANTAB for Traumatic Brain Injury |
| gptkbp:headquarters |
gptkb:Cambridge,_England
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cambridge Cognition
|
| gptkbp:industry |
healthcare
|
| gptkbp:offers |
gptkb:CANTAB
|
| gptkbp:operates_in |
gptkb:Europe
gptkb:Asia gptkb:North_America |
| gptkbp:provides |
data analytics
regulatory support clinical trial support |
| gptkbp:serves |
clinical trials
|
| gptkbp:specializes_in |
cognitive assessment
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
www.cambridgecognition.com
|
| gptkbp:bfsParent |
gptkb:Cambridge_Cluster
|
| gptkbp:bfsLayer |
6
|